Sirdás sisdollui
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Aiddostahtton
  • 3-dose of RBD vaccine is suffi...
  • Čujuhandieđut
  • Deakstadieđáhus
  • Sádde šleađgaboasttain
  • Čálit
  • Doalvvo čujuhusa
    • Doalvun: RefWorks
    • Doalvun: EndNoteWeb
    • Doalvun: EndNote
  • Bissovaš liŋka
3-dose of RBD vaccine is sufficient to elicit a long-lasting memory response against SARS-CoV-2 infection

3-dose of RBD vaccine is sufficient to elicit a long-lasting memory response against SARS-CoV-2 infection

Bibliográfalaš dieđut
Váldodahkkit: Mengqing Cong, Yunru Yang, Haiyang Tong, Ajmeri Sultana Shimu, Baolong Wang, Qing Li, Fengyin Li, Yi Yang, Tengchuan Jin, Bofeng Li
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: Nature Publishing Group 2022-03-01
Ráidu:Signal Transduction and Targeted Therapy
Liŋkkat:https://doi.org/10.1038/s41392-022-00937-9
  • Oažžasuvvandieđut
  • Govvádus
  • Geahča maid
  • Bargiidšearbma

Interneahtta

https://doi.org/10.1038/s41392-022-00937-9

Geahča maid

  • Distinct BCR repertoires elicited by SARS-CoV-2 RBD and S vaccinations in mice
    Dahkki: Siyu Tian, et al.
    Almmustuhtton: (2021-10-01)
  • A three-dose inactivated SARS-CoV-2 vaccine is sufficient to elicit humoral immune responses in people living with HIV-1
    Dahkki: Haisheng Yu, et al.
    Almmustuhtton: (2023-09-01)
  • The presence of broadly neutralizing anti-SARS-CoV-2 RBD antibodies elicited by primary series and booster dose of COVID-19 vaccine
    Dahkki: Chen, X, et al.
    Almmustuhtton: (2024)
  • The presence of broadly neutralizing anti-SARS-CoV-2 RBD antibodies elicited by primary series and booster dose of COVID-19 vaccine.
    Dahkki: Xiaorui Chen, et al.
    Almmustuhtton: (2024-06-01)
  • RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants
    Dahkki: Qingtai Liang, et al.
    Almmustuhtton: (2022-04-01)

Ozu molssaeavttut

  • Ohcanhistorjá
  • Aiddostahtton ohcu

Viečča lasi

  • Bláđe logahallama
  • Bláđe alfabehtalaš ortnegis
  • Dutkka kanálaid
  • Gursagirjjit
  • Ođatlogahallan

Dárbbašatgo veahki?

  • Ohcanráva
  • Jeara girjerájus
  • DJG:t